A 38-year-old woman with a 10-year history of symptomatic varicose veins in the left lower limb presents for definitive management. She reports heaviness, aching, and occasional leg swelling that worsens by evening. Duplex ultrasonography confirms great saphenous vein (GSV) incompetence with reflux >0.5 seconds. She has no skin changes or ulceration. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient has: - Symptomatic varicose veins (heaviness, aching, swelling) - Confirmed GSV incompetence on duplex USS - No skin changes or ulceration (C0–C2 CEAP classification) - Desire for definitive treatment ## Management Algorithm for Symptomatic Varicose Veins ```mermaid flowchart TD A["Symptomatic varicose veins<br/>Duplex USS confirms GSV reflux"]:::outcome --> B{"Patient wishes<br/>definitive treatment?"}:::decision B -->|"No"| C["Conservative management<br/>Compression, elevation, exercise"]:::action B -->|"Yes"| D{"GSV diameter<br/>and extent?"}:::decision D -->|"Suitable for endovenous"| E["EVLA / RFA<br/>First-line minimally invasive"]:::action D -->|"Large diameter<br/>or extensive"|F["Open surgery<br/>High ligation ± stripping"]:::action E --> G["Tumescent anesthesia<br/>Local or twilight sedation"]:::action F --> H["General anesthesia<br/>Higher morbidity"]:::action ``` ## Key Point: **Endovenous laser ablation (EVLA) or radiofrequency ablation (RFA) are now the first-line definitive treatments for symptomatic GSV incompetence.** They have replaced open surgery as the gold standard due to superior safety, efficacy, and patient satisfaction. ## High-Yield: - **EVLA/RFA indications:** Symptomatic varicose veins with confirmed reflux, GSV diameter 3–12 mm, suitable anatomy - **Advantages over open surgery:** Minimally invasive, local/twilight anesthesia, faster recovery, lower morbidity, equivalent efficacy - **Success rates:** EVLA/RFA: 90–98% at 1 year; open surgery: 85–95% (comparable efficacy, but better patient tolerance with endovenous methods) - **Compression therapy alone:** Appropriate for asymptomatic varices or patients unwilling/unable to undergo intervention ## Comparison Table: Definitive Treatment Options | Feature | EVLA/RFA | Open Surgery (High Ligation ± Stripping) | Sclerotherapy | | --- | --- | --- | --- | | **Anesthesia** | Local/twilight | General | Local | | **Invasiveness** | Minimally invasive | Open procedure | Non-invasive | | **Recovery time** | 1–2 weeks | 2–4 weeks | Immediate | | **Success rate (1 yr)** | 90–98% | 85–95% | 70–85% (variable) | | **Recurrence** | 5–15% | 10–20% | 20–30% | | **Complications** | Rare (DVT <1%, nerve injury <1%) | Saphenous nerve injury (10–30%), hematoma, infection | Allergic reaction, phlebitis, matting | | **First-line status** | ✓ Yes | Reserved for failed endovenous or unsuitable anatomy | Adjunct for residual tributaries | | **Patient satisfaction** | Excellent | Good | Moderate | ## Clinical Pearl: **Sclerotherapy is NOT first-line for truncal GSV incompetence.** It is best reserved for residual tributaries after ablation of the main trunk, or for isolated telangiectasias. Foam sclerotherapy has higher success rates than liquid but carries a small risk of systemic embolism. ## Why EVLA/RFA? 1. **Minimally invasive** — performed under local or twilight anesthesia 2. **Faster recovery** — return to normal activities in 1–2 weeks 3. **Lower morbidity** — saphenous nerve injury risk <1% (vs. 10–30% with open surgery) 4. **Equivalent efficacy** — 90–98% success at 1 year 5. **Current evidence-based standard** — NICE, ACCP, and most vascular societies recommend as first-line [cite:Sabiston Textbook of Surgery Ch 65; NICE Guidelines on Varicose Veins]